Lifevantage Corp

LifeVantage Corporation announced that Terrence Moorehead has officially joined the company as President and Chief Executive Officer, and as a member of its Board of Directors. Moorehead's appointment, previously announced in April, brings over 25 years of global leadership experience, including his recent role as President and CEO of Nature's Sunshine Products. The company expressed enthusiasm for his strategic vision and track record of delivering profitable growth.

LifeVantage Corporation reported a significant decline in its third fiscal quarter 2026 results, with revenue decreasing by 25.2% to $43.7 million and diluted EPS falling to $0.11 from $0.26 year-over-year. The decline was primarily attributed to lower sales of the MindBody GLP-1 System, partially offset by the LoveBiome acquisition. Despite the top-line headwinds, the company increased its quarterly cash dividend by 11.1% to $0.05 per share and continued share repurchases, while also adjusting its fiscal year 2026 guidance to the lower end of previous expectations.

Lifevantage Corp reported a significant decline in its third-quarter and nine-month financial results for fiscal year 2026. For the three months ended March 31, 2026, net revenue decreased to $43.7 million and net income fell to $1.36 million, with diluted EPS at $0.11. The company also saw a decrease in cash and cash equivalents and net cash provided by operating activities compared to the prior year, alongside a notable increase in inventory obsolescence allowance.

LifeVantage Corporation announced that its Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock. The dividend is scheduled to be paid on June 15, 2026, to all stockholders of record at the close of business on June 1, 2026. This action reflects the company's ongoing commitment to returning value to its shareholders.

LifeVantage Corporation announced it will release its financial results for the third quarter ended March 31, 2026, after the stock market closes on Wednesday, May 6, 2026. The company will host a conference call for investors on the same day at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time). Investors can access a telephone replay or a live webcast of the call.

LifeVantage Corporation announced it has been granted U.S. Patent No. 12,589,067 B2 for its Healthy Glow Essentials Stack , issued on March 31, 2026. The patent covers the nutritional supplement composition and methods for activating cellular signaling genes, specifically for the product duo of Protandim Nrf2 Synergizer and TrueScience Liquid Collagen. According to the company, compositions of the product improved skin and impacted key regulatory genes associated with cellular pathways, supporting the body's natural ability to combat cellular stress and signs of aging. This patent, resulting from over three years of research, reinforces LifeVantage's position as an innovation leader in the health and wellness industry.

LifeVantage Corporation announced the appointment of Terrence Moorehead as its new President and Chief Executive Officer, effective August 5, 2026. Mr. Moorehead brings over 25 years of leadership experience, including a successful tenure as CEO of Nature's Sunshine Products where he significantly grew revenue and EBITDA. Current CEO Steve Fife's retirement is set for April 30, 2026, with current director Michael Beindorff serving as Interim CEO during the transition period.

LifeVantage Corporation entered into an Independent Contractor Consultant Agreement with Michael Beindorff, effective May 1, 2026. Beindorff, who also serves as a director on the LifeVantage Board, will provide specified services for a fee and be reimbursed for reasonable expenses, including travel between Colorado and Utah. The agreement clarifies his role as an independent contractor for these services, distinct from his board duties.

LifeVantage Corporation announced that its President and CEO, Steve Fife, along with Chief Sales Officer Kristen Cunningham and VP Research & Development and Regulatory Lisa Barnes, will participate in the upcoming Water Tower Research Insights Conference. The presentation is scheduled for Wednesday, April 15, 2026, at approximately 12:30 p.m. Eastern Time. This event provides an opportunity for institutional investors and interested parties to engage directly with the company's senior leadership and gain insights into its strategic initiatives and product portfolio, which includes nutrigenomic activators like Protandim and TrueScience Liquid Collagen. The webcast will be open access, enhancing transparency and investor relations.